Skip to content
Screener

Silicon Laboratories SLAB Business Segments — SG&A

Similar metrics at other companies

Indivior Pharmaceuticals, Inc. logo
INDVReportable Segment — SG&A
$124M-6.8%
VGN
VGNTReportable Segment — SG&A
$97M-7.6%
BridgeBio Pharma logo
BBIOReportable Segment — SG&A
$163.9M+54.1%
QXO, Inc. logo
QXOReportable Segment — SG&A
$457.8M+1,792%
Agios Pharmaceuticals logo
AGIOReportable Segment — SG&A
$51.55M+12.4%
ITG
ITGRReportable Segment — SG&A
$52.94M+14.3%

Other financials

Income statement

See full
Revenue$213.5M+20.1%
Gross profit$127.0M+29.9%
Operating income-$17.1M+46.8%
Net income-$15.9M+47.8%
EPS (diluted)-$0.48+48.9%

Balance sheet

See full
Cash & equivalents$383.1M+17.9%
Total debt$24.0M+11.8%
Total equity$1.1B+2.8%
Total assets$1.3B+3.0%

Cash flow

See full
Operating cash flow$4.9M-89.7%
CapEx$9.8M+103%
Free cash flow-$4.9M-111%

Valuation

See full
Market cap$7.2B+77.2%
P/S8.8×+3.0×

Profitability

See full
Gross margin59.3%+5.1pp
Operating margin-6.8%-2.7pp
Net margin-6.1%-2.6pp
FCF margin-6.3%-21.8pp

Returns & leverage

See full
Return on equity-4.6%-1.9pp
Debt / equity0.0×
Current ratio5.1×-0.1×

Where this comes from

Reported directly by Silicon Laboratories in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Silicon Laboratories’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0001038074-26-000020
Line itemThree Months Ended / April 4,2026Three Months Ended / April 5,2025
Research and development:
Employee base compensation$32,316$32,972
Other research and development expenses (1)56,27855,247
Total research and development$88,594$88,219
Selling, general and administrative:
Employee base compensation$13,775$14,107
Other selling, general and administrative expenses (1)41,71127,531
Total selling, general and administrative$55,486$41,638

Item 1. Financial Statements (Unaudited):

FAQ

What is Silicon Laboratories's business segments — SG&A?
Silicon Laboratories (SLAB) reported business segments — SG&A of $55.49M in Q1 2026.
How has Silicon Laboratories's business segments — SG&A changed year-over-year?
Silicon Laboratories's business segments — SG&A increased by 33.3% year-over-year, from $41.64M to $55.49M.
What is the long-term trend for Silicon Laboratories's business segments — SG&A?
Over 2 years (2023 to 2025), Silicon Laboratories's business segments — SG&A has grown at a 8.9% compound annual growth rate (CAGR), from $147M to $174.28M.
What does business segments — SG&A mean?
This represents the total operating overhead associated with selling, marketing, and general administration for the reportable segment. It is a key measure of the operational cost intensity required to support the segment's market presence and business functions.

Ask your AI about Silicon Laboratories's business segments — sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude